BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El Hachem M, Diociaiuti A, Concato C, Carsetti R, Carnevale C, Ciofi Degli Atti M, Giovannelli L, Latella E, Porzio O, Rossi S, Stracuzzi A, Zaffina S, Onetti Muda A, Zambruno G, Alaggio R. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection. J Eur Acad Dermatol Venereol 2020;34:2620-9. [PMID: 32474947 DOI: 10.1111/jdv.16682] [Cited by in Crossref: 64] [Cited by in F6Publishing: 80] [Article Influence: 32.0] [Reference Citation Analysis]
Number Citing Articles
1 Dondi A, Sperti G, Gori D, Guaraldi F, Montalti M, Parini L, Piraccini BM, Lanari M, Neri I. Epidemiology and clinical evolution of non-multisystem inflammatory syndrome (MIS-C) dermatological lesions in pediatric patients affected by SARS-CoV-2 infection: A systematic review of the literature. Eur J Pediatr 2022. [PMID: 35948654 DOI: 10.1007/s00431-022-04585-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Pendlebury GA, Oro P, Haynes W, Merideth D, Bartling S, Bongiorno MA. The Impact of COVID-19 Pandemic on Dermatological Conditions: A Novel, Comprehensive Review. Dermatopathology (Basel) 2022;9:212-43. [PMID: 35892480 DOI: 10.3390/dermatopathology9030027] [Reference Citation Analysis]
3 Fennell J, Onel K. Chilblains-Like Lesions in Pediatric Patients: A Review of Their Epidemiology, Etiology, Outcomes, and Treatment. Front Pediatr 2022;10:904616. [DOI: 10.3389/fped.2022.904616] [Reference Citation Analysis]
4 Pasquini Neto R, Mazzo FAT, Vieira FA, Bueno GS, Previdi JVC, Silva LRD, Silva NKBD, Jorizzo JL, Cerci FB. COVID-19 cutaneous manifestations in children and adolescents: a systematic review. Rev Paul Pediatr 2022;40:e2021134. [PMID: 35703724 DOI: 10.1590/1984-0462/2022/40/2021134IN] [Reference Citation Analysis]
5 Paparella R, Tarani L, Properzi E, Costantino F, Saburri C, Lucibello R, Richetta A, Spalice A, Leonardi L. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature. Ital J Pediatr 2022;48:93. [PMID: 35698236 DOI: 10.1186/s13052-022-01296-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Agarwal A, Das A, Panda M, Goyal J, Dash M. Cutaneous manifestations of covid-19 in pediatric population: A web based comparative study between the perspectives of dermatologists and pediatricians. CSDM 2022;2:39. [DOI: 10.25259/csdm_40_2022] [Reference Citation Analysis]
7 Panda M, Agarwal A, Hassanandani T. Dermatological Manifestations of COVID-19 in Children. Indian Pediatr 2022;59:393-9. [DOI: 10.1007/s13312-022-2521-6] [Reference Citation Analysis]
8 Bascuas-Arribas M, Andina-Martinez D, Añon-Hidalgo J, Alonso-Cadenas JA, Hernandez-Martin A, Lamagrande-Casanova N, Noguero-Morel L, Mateos-Mayo A, Colmenero-Blanco I, Torrelo A. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic. Pediatr Dermatol 2022. [PMID: 35129855 DOI: 10.1111/pde.14948] [Reference Citation Analysis]
9 Van Wert M, Ghio M, Graham C, Smetherman D, Sanders R, Corsetti R. Multicentric Breast Abscesses in a Patient Who Had COVID-19. Ochsner J 2021;21:402-5. [PMID: 34984056 DOI: 10.31486/toj.21.0095] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Robustelli Test E, Sena P, Locatelli AG, Carugno A, di Mercurio M, Moggio E, Gambini DM, Arosio MEG, Callegaro A, Morotti D, Gianatti A, Vezzoli P. RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study. Pediatr Dermatol 2022. [PMID: 34989043 DOI: 10.1111/pde.14903] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pasquini Neto R, Mazzo FAT, Vieira FDA, Bueno GDS, Previdi JVC, Silva LRD, Silva NKBD, Jorizzo JL, Cerci FB. Manifestações cutâneas da COVID-19 em crianças e adolescentes: uma revisão sistemática. Rev paul pediatr 2022;40:e2021134. [DOI: 10.1590/1984-0462/2022/40/2021134] [Reference Citation Analysis]
12 Dinulos JE, Dinulos JG. Cutaneous coronavirus disease 2019 in children: a clinical primer for diagnosis and treatment. Curr Opin Pediatr 2021;33:691-703. [PMID: 34670262 DOI: 10.1097/MOP.0000000000001076] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Al-Gburi S, Beissert S, Günther C. Molecular mechanisms of vasculopathy and coagulopathy in COVID-19. Biol Chem 2021;402:1505-18. [PMID: 34657406 DOI: 10.1515/hsz-2021-0245] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Mohta A, Mohta A, Nai RS, Arora A, Jain SK, Mohta A, Mehta RD, Ghiya BC, Prasad V, Khokhar R, Toteja R, Bha Rgava G. An Observational Study of Mucocutaneous Manifestations among SARS-CoV-2 Patients from Three COVID-19 Dedicated Tertiary Care Centers. Indian Dermatol Online J 2021;12:687-95. [PMID: 34667754 DOI: 10.4103/idoj.IDOJ_127_21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
15 Poizeau F, Oger E, Barbarot S, Le Corre Y, Samimi M, Brenaut E, Aubert H, Chambrelan E, Droitcourt C, Gissot V, Heslan C, Laurent C, Martin L, Misery L, Tattevin P, Toubel A, Thibault V, Dupuy A. Chilblains during lockdown are associated with household exposure to SARS-CoV-2: a multicentre case-control study. Clin Microbiol Infect 2021:S1198-743X(21)00561-9. [PMID: 34619397 DOI: 10.1016/j.cmi.2021.09.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
16 Agnihothri R, Fox LP. Clinical Patterns and Morphology of COVID-19 Dermatology. Dermatol Clin 2021;39:487-503. [PMID: 34556240 DOI: 10.1016/j.det.2021.05.006] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
17 Gallman AE, Fassett MS. Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease. Dermatol Clin 2021;39:533-43. [PMID: 34556243 DOI: 10.1016/j.det.2021.05.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Neale H, Hawryluk EB. COVID-19 Pediatric Dermatology. Dermatol Clin 2021;39:505-19. [PMID: 34556241 DOI: 10.1016/j.det.2021.05.012] [Reference Citation Analysis]
19 Sánchez-García V, Hernández-Quiles R, de-Miguel-Balsa E, Docampo-Simón A, Belinchón-Romero I, Ramos-Rincón JM. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis. J Eur Acad Dermatol Venereol 2022;36:24-38. [PMID: 34545625 DOI: 10.1111/jdv.17672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 El-Hor N, Adams M. Pediatric Rheumatologic Effects of COVID-19. Pediatr Clin North Am 2021;68:1011-27. [PMID: 34538296 DOI: 10.1016/j.pcl.2021.05.002] [Reference Citation Analysis]
21 Atzori L, Ferreli C, Mateeva V, Vassileva S, Rongioletti F. Clinicopathologic features between different viral epidemic outbreaks involving the skin. Clin Dermatol 2021;39:405-17. [PMID: 34517998 DOI: 10.1016/j.clindermatol.2021.04.002] [Reference Citation Analysis]
22 Panda M, Dash S, Behera B, Sil A. Dermatological Manifestations Associated with COVID-19 Infection. Indian J Dermatol 2021;66:237-45. [PMID: 34446946 DOI: 10.4103/ijd.ijd_464_21] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Kolivras A, Thompson C, Pastushenko I, Mathieu M, Bruderer P, de Vicq M, Feoli F, Harag S, Meiers I, Olemans C, Sass U, Dehavay F, Fakih A, Lam-Hoai XL, Marneffe A, Van De Borne L, Vandersleyen V, Richert B. A clinicopathological description of COVID-19-induced chilblains (COVID-toes) correlated with a published literature review. J Cutan Pathol 2021. [PMID: 34272741 DOI: 10.1111/cup.14099] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
24 Mohseni Afshar Z, Babazadeh A, Hasanpour A, Barary M, Sayad B, Janbakhsh A, Aryanian Z, Ebrahimpour S. Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge. J Med Virol 2021;93:5756-67. [PMID: 34241899 DOI: 10.1002/jmv.27187] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
25 Zacharias H, Dubey S, Koduri G, D'Cruz D. Rheumatological complications of Covid 19. Autoimmun Rev 2021;20:102883. [PMID: 34237419 DOI: 10.1016/j.autrev.2021.102883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
26 Sachdeva M, Mufti A, Maliyar K, Lara-Corrales I, Salcido R, Sibbald C. A Review of COVID-19 Chilblains-like Lesions and Their Differential Diagnoses. Adv Skin Wound Care 2021;34:348-54. [PMID: 34125725 DOI: 10.1097/01.ASW.0000752692.72055.74] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Seth S, Rashid F, Khera K. An overview of the COVID-19 complications in paediatric population: A pandemic dilemma. Int J Clin Pract 2021;75:e14494. [PMID: 34115913 DOI: 10.1111/ijcp.14494] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Hubiche T, Le Duff F, Fontas E, Rapp J, Chiaverini C, Passeron T. Relapse of chilblain-like lesions during the second wave of the COVID-19 pandemic: a cohort follow-up. Br J Dermatol 2021;185:858-9. [PMID: 34128539 DOI: 10.1111/bjd.20584] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Cazzato G, Mazzia G, Cimmino A, Colagrande A, Sablone S, Lettini T, Rossi R, Santarella N, Elia R, Nacchiero E, Maruccia M, Marzullo A, Maiorano E, Giudice G, Ingravallo G, Resta L. SARS-CoV-2 and Skin: The Pathologist's Point of View. Biomolecules 2021;11:838. [PMID: 34200112 DOI: 10.3390/biom11060838] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
30 Méndez-Echevarría A, Sainz T, Falces-Romero I, de Felipe B, Escolano L, Alcolea S, Pertiñez L, Neth O, Calvo C. Long-Term Persistence of Anti-SARS-CoV-2 Antibodies in a Pediatric Population. Pathogens 2021;10:700. [PMID: 34199852 DOI: 10.3390/pathogens10060700] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
31 Akl J, El-Kehdy J, Salloum A, Benedetto A, Karam P. Skin disorders associated with the COVID-19 pandemic: A review. J Cosmet Dermatol 2021. [PMID: 34077629 DOI: 10.1111/jocd.14266] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Discepolo V, Catzola A, Pierri L, Mascolo M, Della Casa F, Vastarella M, Smith G, Travaglino A, Punziano A, Nappa P, Staibano S, Bruzzese E, Fabbrocini G, Guarino A, Alessio M. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic. JAMA Netw Open 2021;4:e2111369. [PMID: 34110396 DOI: 10.1001/jamanetworkopen.2021.11369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
33 Sadeghzadeh-Bazargan A, Rezai M, Najar Nobari N, Mozafarpoor S, Goodarzi A. Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients. J Cutan Pathol 2021. [PMID: 33978234 DOI: 10.1111/cup.14059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
34 Signa S, Sementa AR, Coccia MC, Pastorino C, Viglizzo G, Viola S, Volpi S, Occella C, Bleidl D, Acquila M, Castagnola E, Ravelli A, Manunza F. Recurrence of previous chilblain lesions during the second wave of COVID-19: can we still doubt the correlation with SARS-CoV-2? J Eur Acad Dermatol Venereol 2021;35:e475-7. [PMID: 33871076 DOI: 10.1111/jdv.17283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
35 Corbeddu M, Diociaiuti A, Vinci MR, Santoro A, Camisa V, Zaffina S, El Hachem M. Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series. J Eur Acad Dermatol Venereol 2021;35:e483-5. [PMID: 33834563 DOI: 10.1111/jdv.17268] [Cited by in Crossref: 16] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
36 Ingravallo G, Mazzotta F, Resta L, Sablone S, Cazzato G, Cimmino A, Rossi R, Colagrande A, Ferrante B, Troccoli T, Bonifazi E. Inflammatory Skin Lesions in Three SARS-CoV-2 Swab-Negative Adolescents: A Possible COVID-19 Sneaky Manifestation? Pediatr Rep 2021;13:181-8. [PMID: 33918585 DOI: 10.3390/pediatric13020025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
37 Cazzato G, Foti C, Colagrande A, Cimmino A, Scarcella S, Cicco G, Sablone S, Arezzo F, Romita P, Lettini T, Resta L, Ingravallo G. Skin Manifestation of SARS-CoV-2: The Italian Experience. J Clin Med 2021;10:1566. [PMID: 33917774 DOI: 10.3390/jcm10081566] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
38 Jindal R, Chauhan P, Goyal D, Shirazi N. Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature. Dermatol Ther 2021;34:e14951. [PMID: 33740317 DOI: 10.1111/dth.14951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
39 Neri I, Conti F, Virdi A, Guglielmo A, Leonardi L, Corsini I, Ghizzi C, Gabrielli L, Lazzarotto T, Lanari M, Patrizi A, Misciali C. Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late-onset skin manifestation in previously infected individuals. J Eur Acad Dermatol Venereol 2021;35:e357-9. [PMID: 33651419 DOI: 10.1111/jdv.17194] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
40 Mehta P, Bunker CB, Ciurtin C, Porter JC, Chambers RC, Papdopoulou C, Garthwaite H, Hillman T, Heightman M, Howell KJ, Eleftheriou D, Denton CP. Chilblain-like acral lesions in long COVID-19: management and implications for understanding microangiopathy. Lancet Infect Dis 2021;21:912. [PMID: 33705725 DOI: 10.1016/S1473-3099(21)00133-X] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
41 Visconti A, Bataille V, Rossi N, Kluk J, Murphy R, Puig S, Nambi R, Bowyer RCE, Murray B, Bournot A, Wolf J, Ourselin S, Steves CJ, Spector TD, Falchi M. Diagnostic value of cutaneous manifestation of SARS-CoV-2 infection. Br J Dermatol 2021;184:880-7. [PMID: 33448030 DOI: 10.1111/bjd.19807] [Cited by in Crossref: 12] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
42 Larenas-Linnemann D, Luna-Pech J, Navarrete-Rodríguez EM, Rodríguez-Pérez N, Arias-Cruz A, Blandón-Vijil MV, Del Rio-Navarro BE, Estrada-Cardona A, Onuma-Takane E, Pozo-Beltrán CF, Valencia-Herrera AM, Ortiz-Aldana FI, Toledo-Bahena ME. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group. Curr Allergy Asthma Rep 2021;21:13. [PMID: 33630167 DOI: 10.1007/s11882-020-00986-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
43 Recalcati S, Barbagallo T, Tonolo S, Milani M, Fantini F. Relapse of chilblain-like lesions during the second wave of coronavirus disease 19. J Eur Acad Dermatol Venereol 2021;35:e315-6. [PMID: 33586154 DOI: 10.1111/jdv.17168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
44 Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy. Atherosclerosis 2021;322:39-50. [PMID: 33706082 DOI: 10.1016/j.atherosclerosis.2021.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
45 Singh H, Kaur H, Singh K, Sen CK. Cutaneous Manifestations of COVID-19: A Systematic Review. Adv Wound Care (New Rochelle) 2021;10:51-80. [PMID: 33035150 DOI: 10.1089/wound.2020.1309] [Cited by in Crossref: 40] [Cited by in F6Publishing: 30] [Article Influence: 40.0] [Reference Citation Analysis]
46 Cappel MA, Cappel JA, Wetter DA. Pernio (Chilblains), SARS-CoV-2, and COVID Toes Unified Through Cutaneous and Systemic Mechanisms. Mayo Clin Proc 2021;96:989-1005. [PMID: 33714595 DOI: 10.1016/j.mayocp.2021.01.009] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
47 Zarrilli G, Angerilli V, Businello G, Sbaraglia M, Traverso G, Fortarezza F, Rizzo S, De Gaspari M, Basso C, Calabrese F, Dei Tos AP, Fassan M. The Immunopathological and Histological Landscape of COVID-19-Mediated Lung Injury. Int J Mol Sci 2021;22:974. [PMID: 33478107 DOI: 10.3390/ijms22020974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
48 Marzano AV, Genovese G, Moltrasio C, Gaspari V, Vezzoli P, Maione V, Misciali C, Sena P, Patrizi A, Offidani A, Quaglino P, Arco R, Caproni M, Rovesti M, Bordin G, Recalcati S, Potenza C, Guarneri C, Fabbrocini G, Tomasini C, Sorci M, Lombardo M, Gisondi P, Conti A, Casazza G, Peris K, Calzavara-Pinton P, Berti E;  Italian Skin COVID-19 Network of the Italian Society of Dermatology and Sexually Transmitted Diseases. The clinical spectrum of COVID-19-associated cutaneous manifestations: An Italian multicenter study of 200 adult patients. J Am Acad Dermatol. 2021;84:1356-1363. [PMID: 33476725 DOI: 10.1016/j.jaad.2021.01.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 25] [Article Influence: 11.0] [Reference Citation Analysis]
49 Koschitzky M, Oyola RR, Lee-Wong M, Abittan B, Silverberg N. Pediatric COVID toes and fingers. Clin Dermatol 2021;39:84-91. [PMID: 33972057 DOI: 10.1016/j.clindermatol.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
50 Hubiche T, Phan A, Leducq S, Rapp J, Fertitta L, Aubert H, Barbarot S, Chiaverini C, Giraudeau B, Lasek A, Mallet S, Labarelle A, Piram M, McCuaig C, Martin L, Monitor L, Nicol I, Bissuel M, Bellissen A, Jullien D, Lesort C, Vabres P, Maruani A; Research Group of the Société Française de Dermatologie Pédiatrique (French Society of Pediatric Dermatology). Acute acral eruptions in children during the COVID-19 pandemic: Characteristics of 103 children and their family clusters. Ann Dermatol Venereol 2021;148:94-100. [PMID: 33551211 DOI: 10.1016/j.annder.2020.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
51 Bassi A, Russo T, Argenziano G, Mazzatenta C, Venturini E, Neri I, Piccolo V. Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art. Life (Basel) 2021;11:23. [PMID: 33401712 DOI: 10.3390/life11010023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
52 Hofman P, Copin MC, Tauziede-Espariat A, Adle-Biassette H, Fortarezza F, Passeron T, Salmon I, Calabrese F. [Histopathological features due to the SARS-CoV-2]. Ann Pathol 2021;41:9-22. [PMID: 33446414 DOI: 10.1016/j.annpat.2020.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Rongioletti F, Ferreli C, Sena P, Caputo V, Atzori L. Clinicopathologic correlations of COVID-19-related cutaneous manifestations with special emphasis on histopathologic patterns. Clin Dermatol 2021;39:149-62. [PMID: 33972045 DOI: 10.1016/j.clindermatol.2020.12.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
54 Novelli L, Motta F, De Santis M, Ansari AA, Gershwin ME, Selmi C. The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 - A systematic review of the literature. J Autoimmun 2021;117:102592. [PMID: 33401171 DOI: 10.1016/j.jaut.2020.102592] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
55 Burlando M, Russo R, Cozzani E, Parodi A. Six months into the pandemic. A review of skin manifestations in SARS-CoV-2 infection. Dermatol Ther 2021;34:e14641. [PMID: 33278049 DOI: 10.1111/dth.14641] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Khalili M, Iranmanesh B, Mohammadi S, Aflatoonian M. Cutaneous and histopathological features of coronavirus disease 2019 in pediatrics: A review article. Dermatol Ther 2021;34:e14554. [PMID: 33210417 DOI: 10.1111/dth.14554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
57 Wee C, Tey HL. Chilblain-like eruption in COVID-19 disease: possible pathogenetic role of temperature. Eur J Dermatol 2020;30:764-5. [PMID: 33319768 DOI: 10.1684/ejd.2020.3943] [Reference Citation Analysis]
58 Atzori L, Recalcati S, Ferreli C, Hoenig L, Rongioletti F. COVID-19–related skin manifestations: Update on therapy. Clinics in Dermatology 2020. [DOI: 10.1016/j.clindermatol.2020.12.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
59 Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertitta L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 3. Clin Exp Dermatol 2021;46:462-72. [PMID: 33207021 DOI: 10.1111/ced.14483] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
60 Andina D, Belloni-Fortina A, Bodemer C, Bonifazi E, Chiriac A, Colmenero I, Diociaiuti A, El-Hachem M, Fertitta L, van Gysel D, Hernández-Martín A, Hubiche T, Luca C, Martos-Cabrera L, Maruani A, Mazzotta F, Akkaya AD, Casals M, Ferrando J, Grimalt R, Grozdev I, Kinsler V, Morren MA, Munisami M, Nanda A, Novoa MP, Ott H, Pasmans S, Salavastru C, Zawar V, Torrelo A; ESPD Group for the Skin Manifestations of COVID-19. Skin manifestations of COVID-19 in children: Part 1. Clin Exp Dermatol 2021;46:444-50. [PMID: 33180982 DOI: 10.1111/ced.14481] [Cited by in Crossref: 6] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
61 Brumfiel CM, DiLorenzo AM, Petronic-Rosic VM. Dermatologic manifestations of COVID-19-associated multisystem inflammatory syndrome in children. Clin Dermatol 2021;39:329-33. [PMID: 34272031 DOI: 10.1016/j.clindermatol.2020.10.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
62 Techasatian L, Lebsing S, Uppala R, Thaowandee W, Chaiyarit J, Supakunpinyo C, Panombualert S, Mairiang D, Saengnipanthkul S, Wichajarn K, Kiatchoosakun P, Kosalaraksa P. The Effects of the Face Mask on the Skin Underneath: A Prospective Survey During the COVID-19 Pandemic. J Prim Care Community Health. 2020;11:2150132720966167. [PMID: 33084483 DOI: 10.1177/2150132720966167] [Cited by in Crossref: 12] [Cited by in F6Publishing: 36] [Article Influence: 6.0] [Reference Citation Analysis]
63 Diociaiuti A, Giancristoforo S, Terreri S, Corbeddu M, Concato C, Ciofi Degli Atti M, Zambruno G, Carsetti R, El Hachem M. Are SARS‐CoV‐2 IgA antibodies in paediatric patients with chilblain‐like lesions indicative of COVID‐19 asymptomatic or paucisymptomatic infection? J Eur Acad Dermatol Venereol 2021;35. [DOI: 10.1111/jdv.16934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
64 Denton CP, Campochiaro C, Bruni C, Distler O, Iagnocco A, Matucci Cerinic M. COVID-19 and systemic sclerosis: Rising to the challenge of a pandemic. Journal of Scleroderma and Related Disorders 2021;6:58-65. [DOI: 10.1177/2397198320963393] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
65 Baeck M, Herman A. COVID toes: where do we stand with the current evidence? Int J Infect Dis 2021;102:53-5. [PMID: 33075530 DOI: 10.1016/j.ijid.2020.10.021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
66 Beato Merino MJ, Diago A, Fernández-Flores Á, Fraga J, García Herrera A, Garrido M, Idoate Gastearena MÁ, Llamas-Velasco M, Monteagudo C, Onrubia J, Pérez-González YC, Pérez Muñoz N, Ríos-Martín JJ, Ríos-Viñuela E, Rodríguez Peralto JL, Rozas Muñoz E, Sanmartín O, Santonja C, Santos-Briz Á, Saus C, Suárez Peñaranda JM, Velasco Benito V. Clinical and Histopathologic Characteristics of the Main Causes of Vascular Occlusion - Part I: Thrombi. Actas Dermosifiliogr (Engl Ed) 2021;112:1-13. [PMID: 33045208 DOI: 10.1016/j.ad.2020.09.006] [Reference Citation Analysis]
67 Fertitta L, Welfringer-Morin A, Ouedrani A, Polivka L, Chhun S, Chatenoud L, Fourgeaud J, Hadj-Rabia S, Temmam S, Eloit M, Sermet-Gaudelus I, Bodemer C. Immunological and virological profile of children with chilblain-like lesions and SARS-CoV-2. J Eur Acad Dermatol Venereol 2021;35:e164-7. [PMID: 33010072 DOI: 10.1111/jdv.16972] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
68 Adekiigbe R, Ugbode F, Seoparson S, Katriyar N, Fetterman A. A 47-Year-Old Hispanic Man Who Developed Cutaneous Vasculitic Lesions and Gangrene of the Toes Following Admission to Hospital with COVID-19 Pneumonia. Am J Case Rep 2020;21:e926886. [PMID: 32999267 DOI: 10.12659/AJCR.926886] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
69 Ko CJ, Harigopal M, Gehlhausen JR, Bosenberg M, McNiff JM, Damsky W. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. J Cutan Pathol 2021;48:47-52. [PMID: 32895985 DOI: 10.1111/cup.13866] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
70 Becker RC. COVID-19-associated vasculitis and vasculopathy. J Thromb Thrombolysis 2020;50:499-511. [PMID: 32700024 DOI: 10.1007/s11239-020-02230-4] [Cited by in Crossref: 77] [Cited by in F6Publishing: 110] [Article Influence: 38.5] [Reference Citation Analysis]
71 Allez M, Denis B, Bouaziz JD, Battistella M, Zagdanski AM, Bayart J, Lazaridou I, Gatey C, Pillebout E, Chaix Baudier ML, Delaugerre C, Molina JM, Le Goff J. COVID-19-Related IgA Vasculitis. Arthritis Rheumatol 2020;72:1952-3. [PMID: 32633104 DOI: 10.1002/art.41428] [Cited by in Crossref: 14] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
72 Balestri R, Magnano M, Rizzoli L, Rech G. Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature. Dermatol Ther 2020;33:e14229. [PMID: 32844512 DOI: 10.1111/dth.14229] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
73 Ko CJ, Harigopal M, Damsky W, Gehlhausen JR, Bosenberg M, Patrignelli R, McNiff JM. Perniosis during the COVID-19 pandemic: Negative anti-SARS-CoV-2 immunohistochemistry in six patients and comparison to perniosis before the emergence of SARS-CoV-2. J Cutan Pathol 2020;47:997-1002. [PMID: 32745281 DOI: 10.1111/cup.13830] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
74 Li H, Zhao Y, Zhou L, Hu J. Cutaneous, skin histopathological manifestations and relationship to COVID-19 infection patients. Dermatol Ther 2020;33:e14157. [PMID: 32770717 DOI: 10.1111/dth.14157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
75 Le Cleach L, Dousset L, Assier H, Fourati S, Barbarot S, Boulard C, Bourseau Quetier C, Cambon L, Cazanave C, Colin A, Kostrzewa E, Lesort C, Levy Roy A, Lombart F, Marco-Bonnet J, Monfort JB, Samimi M, Tardieu M, Wolkenstein P, Sbidian E, Beylot-Barry M; French Society of Dermatology. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing. Br J Dermatol 2020;183:866-74. [PMID: 32628270 DOI: 10.1111/bjd.19377] [Cited by in Crossref: 28] [Cited by in F6Publishing: 34] [Article Influence: 14.0] [Reference Citation Analysis]
76 Navarro L, Andina D, Noguera-Morel L, Hernández-Martín A, Colmenero I, Torrelo A. Dermoscopy features of COVID-19-related chilblains in children and adolescents. J Eur Acad Dermatol Venereol 2020;34:e762-4. [PMID: 32618033 DOI: 10.1111/jdv.16800] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
77 Visveswaran GK, Morparia K, Narang S, Sturt C, Divita M, Voigt B, Hawatmeh A, McQueen D, Cohen M. Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Thrombosis: Phlegmasia Cerulea Dolens Presenting with Venous Gangrene in a Child. J Pediatr 2020:S0022-3476(20)30875-1. [PMID: 32673617 DOI: 10.1016/j.jpeds.2020.07.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
78 Tabary M, Khanmohammadi S, Araghi F, Dadkhahfar S, Tavangar SM. Pathologic features of COVID-19: A concise review. Pathol Res Pract. 2020;216:153097. [PMID: 32825963 DOI: 10.1016/j.prp.2020.153097] [Cited by in Crossref: 34] [Cited by in F6Publishing: 40] [Article Influence: 17.0] [Reference Citation Analysis]
79 De Rose DU, Auriti C, Landolfo F, Capolupo I, Salvatori G, Ranno S, Concato C, Braguglia A, Bagolan P, Dotta A. Reshaping neonatal intensive care units (NICUs) to avoid the spread of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) to high-risk infants. Infect Control Hosp Epidemiol 2021;42:632-3. [PMID: 32576333 DOI: 10.1017/ice.2020.310] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
80 Lipsker D. Paraviral eruptions in the era of COVID-19: Do some skin manifestations point to a natural resistance to SARS-CoV-2? Clin Dermatol 2020;38:757-61. [PMID: 33341210 DOI: 10.1016/j.clindermatol.2020.06.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]